Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, “Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H2, 2013" provides data on the Chemotherapy Induced Nausea and Vomiting clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chemotherapy Induced Nausea and Vomiting. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chemotherapy Induced Nausea and Vomiting. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Chemotherapy Induced Nausea and Vomiting 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 21
Clinical Trials in E7 Nations by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Unaccomplished Trials of Chemotherapy Induced Nausea and Vomiting 26
Subjects Recruited Over a Period of Time 30
Prominent Sponsors 31
Top Companies Participating in Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials 33
Prominent Drug Comparison 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Merck and Co., Inc. 36
Clinical Trial Overview of Merck and Co., Inc. 36
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Helsinn Healthcare S.A. 40
Clinical Trial Overview of Helsinn Healthcare S.A. 40
ProStrakan Group plc 42
Clinical Trial Overview of ProStrakan Group plc 42
Tesaro, Inc. 43
Clinical Trial Overview of Tesaro, Inc. 43
Acacia Pharma Ltd. 44
Clinical Trial Overview of Acacia Pharma Ltd. 44
Mylan Pharmaceuticals Inc. 45
Clinical Trial Overview of Mylan Pharmaceuticals Inc. 45
A.P. Pharma, Inc. 46
Clinical Trial Overview of A.P. Pharma, Inc. 46
Par Pharmaceutical Companies, Inc. 47
Clinical Trial Overview of Par Pharmaceutical Companies, Inc. 47
Ono Pharmaceutical Co., Ltd. 48
Clinical Trial Overview of Ono Pharmaceutical Co., Ltd. 48
Insys Therapeutics, Inc. 49
Clinical Trial Overview of Insys Therapeutics, Inc. 49
RedHill Biopharma Ltd. 50
Clinical Trial Overview of RedHill Biopharma Ltd. 50
Dr. Reddy's Laboratories Limited 51
Clinical Trial Overview of Dr. Reddy's Laboratories Limited 51
Solasia Pharma K.K. 52
Clinical Trial Overview of Solasia Pharma K.K. 52
LG Life Sciences, Ltd. 53
Clinical Trial Overview of LG Life Sciences, Ltd. 53
IPCA Laboratories Limited 54
Clinical Trial Overview of IPCA Laboratories Limited 54
Eisai Inc. 55
Clinical Trial Overview of Eisai Inc. 55
Halozyme Therapeutics, Inc. 56
Clinical Trial Overview of Halozyme Therapeutics, Inc. 56
Schering-Plough Corporation (Inactive) 57
Clinical Trial Overview of Schering-Plough Corporation (Inactive) 57
Teva Pharmaceutical Industries Limited 58
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 58
Clinical Trial Overview of Top Institutes / Government 59
The University of Texas M. D. Anderson Cancer Center 59
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 59
University of Rochester 60
Clinical Trial Overview of University of Rochester 60
Memorial Sloan Kettering Cancer Center 61
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 61
Kitasato University School of Medicine 62
Clinical Trial Overview of Kitasato University School of Medicine 62
Duke University 63
Clinical Trial Overview of Duke University 63
OHSU Knight Cancer Institute 64
Clinical Trial Overview of OHSU Knight Cancer Institute 64
Yokohama City University 65
Clinical Trial Overview of Yokohama City University 65
Tokushima University Hospital 66
Clinical Trial Overview of Tokushima University Hospital 66
Washington University School of Medicine 67
Clinical Trial Overview of Washington University School of Medicine 67
National Cancer Institute 68
Clinical Trial Overview of National Cancer Institute 68
University of Oklahoma 69
Clinical Trial Overview of University of Oklahoma 69
Kyoto University 70
Clinical Trial Overview of Kyoto University 70
University of Washington 71
Clinical Trial Overview of University of Washington 71
All India Institute of Medical Sciences 72
Clinical Trial Overview of All India Institute of Medical Sciences 72
The Hospital for Sick Children 73
Clinical Trial Overview of The Hospital for Sick Children 73
Thomas Jefferson University 74
Clinical Trial Overview of Thomas Jefferson University 74
Gynecologic Oncology Group 75
Clinical Trial Overview of Gynecologic Oncology Group 75
Kobe University 76
Clinical Trial Overview of Kobe University 76
The University of Manchester 77
Clinical Trial Overview of The University of Manchester 77
Shizuoka Cancer Center 78
Clinical Trial Overview of Shizuoka Cancer Center 78
Five Key Clinical Profiles 79
Appendix 153
Abbreviations 153
Definitions 153
Research Methodology 154
Secondary Research 154
About GlobalData 155
Contact Us 155
Disclaimer 155
Source 156




List of Tables

Chemotherapy Induced Nausea and Vomiting Therapeutics Market, Global, Clinical Trials by Zone, 2013* 9
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 12
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 13
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, North America, Top Countries, 2013* 14
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 15
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 16
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, BRIC Countries, 2013* 17
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, G7 Countries, 2013* 18
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 20
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, E7 Countries, 2013* 21
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 22
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, Global, Clinical Trials by Phase, 2013* 23
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 24
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 25
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, Global, Suspended Clinical Trials, 2013* 26
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 27
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, Global, Terminated Clinical Trials, 2013* 28
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 30
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 32
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 34
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 35
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2013* 36
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 38
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinn Healthcare S.A., 2013* 40
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by ProStrakan Group plc, 2013* 42
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Tesaro, Inc., 2013* 43
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Acacia Pharma Ltd., 2013* 44
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan Pharmaceuticals Inc., 2013* 45
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by A.P. Pharma, Inc., 2013* 46
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Par Pharmaceutical Companies, Inc., 2013* 47
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Pharmaceutical Co., Ltd., 2013* 48
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Insys Therapeutics, Inc., 2013* 49
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by RedHill Biopharma Ltd., 2013* 50
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2013* 51
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Solasia Pharma K.K., 2013* 52
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by LG Life Sciences, Ltd., 2013* 53
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by IPCA Laboratories Limited, 2013* 54
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2013* 55
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Halozyme Therapeutics, Inc., 2013* 56
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Schering-Plough Corporation (Inactive), 2013* 57
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2013* 58
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2013* 59
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2013* 60
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2013* 61
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Kitasato University School of Medicine, 2013* 62
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013* 63
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by OHSU Knight Cancer Institute, 2013* 64
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2013* 65
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokushima University Hospital, 2013* 66
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2013* 67
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2013* 68
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oklahoma, 2013* 69
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2013* 70
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2013* 71
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2013* 72
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2013* 73
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2013* 74
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Gynecologic Oncology Group, 2013* 75
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2013* 76
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Manchester, 2013* 77
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials Market, Global, Clinical Trials by Shizuoka Cancer Center, 2013* 78

List of Figures
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 9
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 12
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 13
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 14
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 15
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 16
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, BRIC Countries (%), 2013* 17
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, G7 Countries (%), 2013* 18
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, E7 Countries (%), 2013* 21
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 22
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 23
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 24
Chemotherapy Induced Nausea and Vomiting Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 25
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 30
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 31
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 33
Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 35
GlobalData Methodology 154

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Therapeutics for Women%s Health: Technologies and Global Markets

Therapeutics for Women%s Health: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • May 2014
  • by BCC Research

Use this report to: - Learn about the main women's health disorders and relevant disease prevalence population. - Identify the impact of demographic, economic, and other factors that will drive future ...

Chronic Lymphocytic Leukaemia: KOL Insight

Chronic Lymphocytic Leukaemia: KOL Insight

  • $ 5 369
  • Industry report
  • May 2014
  • by Firstword Pharma

Chronic lymphocytic leukaemia (CLL) is the most common of the leukaemias, but until recently it has been underserved in terms of effective therapeutic options. However, a revolution in personalised and ...

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations

  • $ 4 995
  • Industry report
  • July 2014
  • by GBI Research

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations Summary GBI Research has released the pharma report, “ADHD Therapeutics ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.